Specifically for colorectal cancer cell lines, BRAF mutant cell lines display also greater sensitivity to inhibitor WZ4003 compared to BRAF wild type colorectal cancer cell lines (mean IC50: 63.7 μM versus 132 μM), although, due to smaller numbers, this difference did not reach statistical significance ( p = 0.08). 4.
← all excerpts
Sensitivities and Dependencies of <i>BRAF</i> Mutant Colorectal Cancer Cell Lines with or without <i>PIK3CA</i> Mutations for Discovery of Vulnerabilities with Therapeutic Potential.
1
0.0800
0.0800